Prostate Cancer Transatlantic Consortium (CaPTC)
Keep up with the latest CaPTC activities on Twitter @CaPTC7.
Because the problem of prostate cancer disparity persists, it is crucial that we begin to use new paradigms and look at the problem from fresh perspectives to develop effective solutions. The possibility for exploring new paradigms comes from studying Blacks who are connected to the U.S. via the Transatlantic Slave Trade.
CaPTC Nigeria Workshop - March 9, 2017 - Abeokuta, Nugeria
The Prostate Cancer Transatlantic Consortium (CaPTC) was formed in 2005 to address the globally disproportionate burden of prostate cancer among Black men. CaPTC is an open consortium comprising a team of prostate cancer scientists, clinicians, survivors, and advocates from North America, Europe, the Caribbean Islands, and West Africa.
CaPTC's research goals are to:
- explore and quantify the magnitude of prostate cancer morbidity and mortality variance among Black men;
- explore the genetic and environmental etiology of this variance, using valid and reliable instruments and biomarkers; and
- develop ethnically sensitive, targeted approaches that will eliminate globally the prostate cancer disparities of Black men through modifiable risk factors associated with prostate cancer.
Administrative leadership of CaPTC comprises the Consortium Director, Scientific Advisory Board, and the Community Advisory Board.
Additionally, members of CaPTC have formed working groups focused on translational research, education and training, and advocacy.
CaPTC organizes biennial conferences on "The Science of Global Prostate Cancer Disparities in Black Men." The first conference, held in 2010, was supported by NCI's Division of Cancer Control and Population Sciences (DCCPS) and the Division of Cancer Prevention (DCP).
|CaPTC Conference Date||Location|
|November, 2018||Lagos, Nigeria|
|November 9-12, 2016||Orlando, Florida, US|
|November 5-8, 2014||Montego Bay, Jamaica [PDF - 214 KB]|
|November 1-4, 2012||Nassau, The Bahamas [PDF]|
|August 27-29, 2010||Jacksonville, Florida, US|
Anyone who is interested in eliminating the worldwide disproportionate burden of prostate cancer in black men can join the CaPTC.
Transatlantic Prostate Cancer Familial Project
The long-term goal of this CaPTC research program is to eliminate the prostate cancer disparity experienced by Black men globally. In line with this goal, this project focuses on understanding genetic, environmental and behavioral etiology of prostate cancer in West African men. Using the principles of Community Engagement Research (CEnR), the following aims will be pursued to achieve the primary objective of this project:
- Specific Aim 1: Create a prospective familial cohort of West African Black men (WABM Familial Cohort) in the United States who can be followed annually to better understand the bio-behavioral etiology of prostate cancer among West African men.
- Specific Aim 2: Using a REDCap database, integrate the United States WABM Familial Cohort data with an international WABM Familial Cohort data of Nigerian and Cameroonian men to better understand the bio-behavioral etiology of prostate cancer among West African men.
Participating CaPTC Familial Project Sites
|U.S. Sites||Principal Investigators|
|University of Florida||Folakemi Odedina|
|Tuskegee University||Clayton Yates|
|Sites in Nigeria – Region 1||Principal Investigators|
|Covenant Universtity||Dr. Emeka.E.J Iweala|
|Lagos University Teaching Hospital||Dr. Anthonia Sowumni|
|Lagos State University Teaching Hospital||Dr. Omolara Fatriegun|
|Federal University of Agriculture Abeokuta||Dr. Catherine Adebukola Badejo|
|Ace Medicare Clinics Limited, Ota||Dr. O.O. Kukoyi|
|University of Calabar||Dr. Iya Eze Bassey|
|Federal Medical Center, Abeokuta||Dr. Chidiebere Ndukwe OGO|
|Sites in Nigeria – Region 2||Principal Investigators|
|Obafemi Awolowo University Teaching Hospitals||Prof. A.A. Salako|
|Ahmadu Bello University||Dr. Mohammed Faruk|
|University of Ilorin||Dr. Ademola Popoola|
|University of Maiduguri||Prof. H. A. Nggada|
|University of Abuja||Dr. Paul Jibrin|
|University of Ibadan||Dr. Adenike Onibokun|
|University of Nigeria||Prof. Iheanyi Okpala|
|Cameroon Site||Principal Investigator|
|University Hospital Center Yaounde||Blaise Nkegoum|
- Damali Martin, Ph.D., M.P.H., Program Director, Genomic Epidemiology Branch, Epidemiology and Genomics Research Program (EGRP), DCCPS, NCI